Viewing Study NCT02736266


Ignite Creation Date: 2025-12-24 @ 4:14 PM
Ignite Modification Date: 2026-01-01 @ 9:40 AM
Study NCT ID: NCT02736266
Status: COMPLETED
Last Update Posted: 2023-07-18
First Post: 2016-04-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module